Advancis Changes Name to MiddleBrook Pharmaceuticals, Inc

The Germantown pharmaceutical company will still focus on developing and commercializing anti-infective products but it needed to take a new identity to settle a dispute over its original name with European drug maker sanofi-aventis.

The company said it will change its NASDAQ trading symbol to MBRK, effective with the start of trading on June 29.

By Dan Beyers  |  June 28, 2007; 8:09 AM ET  | Category:  Middlebrook Pharmaceuticals
Previous: Va. Energy Giant To Buy Back Shares | Next: Digging Up the Streets in Manassas


Please email us to report offensive comments.

The comments to this entry are closed.

RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company